fbpx Dr. Annette Hay appointed SEAMO Chair in Research and Innovation | Faculty of Health Sciences | Queen's University Skip to main content
Dr. Annette Hay

Dr. Annette Hay appointed SEAMO Chair in Research and Innovation

On the recommendation of Dean Jane Philpott, Teri Shearer, Interim Provost and Vice-Principal (Academic) has appointed Dr. Annette Hay as the inaugural SEAMO Chair in Research and Innovation in the School of Medicine effective July 1, 2023, for a five-year term. Her appointment was recommended by the Advisory Search Committee, chaired by Dr. Diane Lougheed, Vice-Dean (Clinical), School of Medicine and Medical Director of Southeastern Ontario Academic Medical Organization (SEAMO).  

As Chair, Dr. Hay will foster and enable interdisciplinary, patient-centred research and support and strengthen current areas of research and innovation throughout the School. She will also conduct new research to help attract funding, research partners and clinician scientists to Queen’s, and strengthen its reputation as a leader in medical research and education. Her broad research interests and experience in clinical trials, data management, health equity and policy make her an ideal candidate to hold this Chair position. 

Dr. Hay is an award-winning hematologist and clinician scientist in the Department of Medicine with cross appointments in the Departments of Oncology and Pediatrics where she is a Professor and Chair of the Division of Hematology. She is also a Senior Investigator with the Canadian Cancer Trials Group (CCTG) working to develop and conduct clinical trials for patients with blood malignancies, perform economic evaluations of cancer interventions, and improve opportunities for adolescents and young adults with cancer to participate in clinical research.  

Dr. Hay earned her MB ChB from the University of Dundee in 2001 and completed her medical and hematology training in Scotland. In 2012, she moved to Canada for a 30-month fellowship with the CCTG. Her distinctions include the prestigious John H. Crookston Award from the Canadian Hematology Society for research on the treatment of Hodgkin Lymphoma. 

Dr. Hay delivered a Cinq à Sept Research Talk in March 2022 about her research journey exploring CAR T-cell therapy for cancer.   

Please join Dean Philpott in congratulating Dr. Hay on her appointment. 

Related topics